Foxd2-KO Mouse
Common Name
Foxd2-KO
제품 ID
S-KO-17923
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-17301-Foxd2-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Foxd2-KO Mouse (카탈로그 번호 S-KO-17923)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Foxd2-KO
품종 계통계통 ID
KOCMP-17301-Foxd2-B6J-VB
유전자명
제품 ID
S-KO-17923
유전자 별칭
Mf2
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 4
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000068654
NCBI 전사체 ID
NM_008593
타겟 영역
Exon 1
유효 영역 크기
~3.4 kb
유전자 연구 개요
Foxd2, belonging to the Forkhead-box (FOX) gene family, is likely involved in a range of biological processes. Although the provided references mainly focus on FOXD2-AS1, a long non-coding RNA, it's worth noting that genes in the FOX family are associated with various functions, and deregulation can lead to congenital disorders, diabetes, or carcinogenesis [7].
Most of the references center on FOXD2-AS1 rather than Foxd2 itself. FOXD2-AS1 is up-regulated in almost all types of malignancies and impacts multiple pathways such as PI3K/AKT, AKT/mTOR, Hippo/YAP, Notch, Nrf2, Wnt/β-catenin, NF-κB, and ERK/MAPK. It enhances cancer stem cell properties, prompts epithelial-mesenchymal transition, and induces resistance to many anticancer agents [1]. In various cancers like gastric, lung, bladder, etc., its up-regulation contributes to cancer cell proliferation, migration, and invasion, and is related to patient survival and prognosis [2,3]. In glioma, it stimulates progression by inhibiting P53 [4]. In esophageal squamous cell carcinoma, it acts as an oncogene by sponging miR-204-3p [5]. In lung adenocarcinoma, it increases proliferation and invasion via cell-cycle regulation [6]. In retinoblastoma, it promotes cell viability and migration by sponging miR-31 [8]. In hepatocellular carcinoma, it facilitates progression by regulating TWIST1 [9]. In osteoarthritis, it induces chondrocyte proliferation by sponging miR-27a-3p [10].
In conclusion, while direct functional studies on Foxd2 from the provided references are scarce, the associated lncRNA FOXD2-AS1 clearly plays significant roles in cancer progression and other disease conditions. Understanding the functions of Foxd2 and its related molecules like FOXD2-AS1 is crucial for uncovering disease mechanisms and developing potential therapeutic strategies.
References:
1. Ghafouri-Fard, Soudeh, Harsij, Atefeh, Hussen, Bashdar Mahmud, Pourmoshtagh, Hasan, Taheri, Mohammad. 2024. A review on the role of FOXD2-AS1 in human disorders. In Pathology, research and practice, 254, 155101. doi:10.1016/j.prp.2024.155101. https://pubmed.ncbi.nlm.nih.gov/38211387/
2. Hu, Qiuhui, Tai, Sheng, Wang, Jicai. 2019. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers. In Pathology, research and practice, 215, 843-848. doi:10.1016/j.prp.2019.01.033. https://pubmed.ncbi.nlm.nih.gov/30723052/
3. Zhang, Yongping, Liang, Chaojie, Zhang, Yu, Wei, Zhigang, Guo, Jiansheng. . The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles. In Bioscience reports, 40, . doi:10.1042/BSR20190372. https://pubmed.ncbi.nlm.nih.gov/33140822/
4. Zhao, Q-S, Ying, J-B, Jing, J-J, Wang, S-S. . LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53. In European review for medical and pharmacological sciences, 24, 4382-4388. doi:10.26355/eurrev_202004_21019. https://pubmed.ncbi.nlm.nih.gov/32373975/
5. Luo, Dongbo, Salai, Adili, Lv, Hongbo, Wang, Yang, Gao, Yunfei. 2022. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 24, 1954-1963. doi:10.1007/s12094-022-02850-7. https://pubmed.ncbi.nlm.nih.gov/35778646/
6. Yuan, Yuan, Yu, Peng, Shen, Huihua, Xing, Guozhu, Li, Wu. 2023. LncRNA FOXD2-AS1 Increased Proliferation and Invasion of Lung Adenocarcinoma via Cell-Cycle Regulation. In Pharmacogenomics and personalized medicine, 16, 99-109. doi:10.2147/PGPM.S396866. https://pubmed.ncbi.nlm.nih.gov/36761100/
7. Katoh, Masuko, Katoh, Masaru. . Human FOX gene family (Review). In International journal of oncology, 25, 1495-500. doi:. https://pubmed.ncbi.nlm.nih.gov/15492844/
8. Liang, Yan, Wang, Hong, Song, Ruiying, Yin, Xiuyan. 2022. lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31. In BioMed research international, 2022, 7723425. doi:10.1155/2022/7723425. https://pubmed.ncbi.nlm.nih.gov/35782084/
9. Chen, G, Zhang, W-L, Zhang, S-M, Tang, K-L, Zhang, Y. . LncRNA FOXD2-AS1 facilitates the progression of hepatocellular carcinoma by regulating TWIST1. In European review for medical and pharmacological sciences, 27, 4536-4543. doi:10.26355/eurrev_202305_32460. https://pubmed.ncbi.nlm.nih.gov/37259735/
10. Wang, Yang, Cao, Lei, Wang, Qiugen, Huang, Jianhua, Xu, Shuogui. . LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging miR-27a-3p in osteoarthritis. In Artificial cells, nanomedicine, and biotechnology, 47, 1241-1247. doi:10.1080/21691401.2019.1596940. https://pubmed.ncbi.nlm.nih.gov/30945573/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
